JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Clinical trial NCT06892431 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06892431
Sponsor: Shanghai JMT-Bio Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic Nasopharyngeal Cancer Patients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy

Start date: 2025-04-01
Primary completion: 2025-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.